Cargando…
Chloroquine Suppresses Effector B-Cell Functions and Has Differential Impact on Regulatory B-Cell Subsets
OBJECTIVES: Chloroquine (CQ) is approved for treatment of B-cell mediated diseases such as rheumatoid arthritis and systemic lupus erythematosus. However, the exact mode of action in these diseases has not been studied and it remains unclear which effect CQ has on B-cells. Thus, it was the aim of th...
Autores principales: | Ma, Xin, Dai, Yang, Witzke, Oliver, Xu, Shilei, Lindemann, Monika, Kribben, Andreas, Dolff, Sebastian, Wilde, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860819/ https://www.ncbi.nlm.nih.gov/pubmed/35211119 http://dx.doi.org/10.3389/fimmu.2022.818704 |
Ejemplares similares
-
IL-22 production of effector CD4(+) T-cells is altered in SLE patients
por: Dolff, Sebastian, et al.
Publicado: (2019) -
BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease
por: Oster, Christoph, et al.
Publicado: (2019) -
B-cell dynamics during experimental endotoxemia in humans
por: Brinkhoff, Alexandra, et al.
Publicado: (2019) -
Abnormal Expression Pattern of the IL-2 Receptor β-Chain on CD4(+) T Cells in ANCA-Associated Vasculitis
por: Wilde, Benjamin, et al.
Publicado: (2014) -
Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
por: Brinkhoff, Alexandra, et al.
Publicado: (2018)